Please login to the form below

Not currently logged in
Email:
Password:

Vir Biotechnology

This page shows the latest Vir Biotechnology news and features for those working in and with pharma, biotech and healthcare.

Lilly, Vir and GSK’s antibodies reduce viral load by 70% in low-risk COVID-19 patients

Lilly, Vir and GSK’s antibodies reduce viral load by 70% in low-risk COVID-19 patients

Eli Lilly, Vir Biotechnology and GlaxoSmithKline’s (GSK) neutralising antibodies have demonstrated positive results in a mid-stage study in low-risk COVID-19 patients. ... Bamlanivimab administered with VIR-7831 also demonstrated a statistically

Latest news

More from news
Approximately 5 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Decibel Therapeutics expands leadership team Decibel Therapeutics expands leadership team

    Finally, Dr Scangos (pictured below left) has recently become chief executive officer of viral and bacterial diseases specialist Vir Biotechnology, having previously served as chief executive officer of Biogen from 2010 ... Prior to this, he was

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics